⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PHARM News
Pharming Group announces approval of Joenja® (leniolisib) in Japan for the treatment of APDS in patients aged 4 years and older
globenewswire.com
PHAR
PHARM
Pharming Group reports fourth quarter and full year 2025 financial results, delivering strong revenue growth and profitability with positive cash flow
globenewswire.com
PHAR
PHARM
Pharming Group to report fourth quarter and full year 2025 financial results and provide business update on March 12
globenewswire.com
PHAR
PHARM
Pharming Group to present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
globenewswire.com
PHARM
PHAR
Pharming Group announces 2026 financial guidance and highlights rare disease pipeline at Investor Day
globenewswire.com
PHARM
PHAR
Pharming Group receives Complete Response Letter from U.S. FDA for sNDA for Joenja® (leniolisib) in children aged 4 to 11 years with APDS
globenewswire.com
PHARM
PHAR